Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 3 | 2023 | 66 | 1.870 |
Why?
|
| Particulate Matter | 3 | 2025 | 80 | 1.750 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2025 | 20 | 1.630 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 242 | 1.090 |
Why?
|
| Florida | 12 | 2025 | 461 | 1.030 |
Why?
|
| Pregnancy | 12 | 2025 | 1733 | 0.960 |
Why?
|
| Diabetes, Gestational | 2 | 2023 | 55 | 0.940 |
Why?
|
| Risk Factors | 15 | 2025 | 3933 | 0.920 |
Why?
|
| Maternal Exposure | 1 | 2025 | 56 | 0.860 |
Why?
|
| Quality of Life | 2 | 2019 | 598 | 0.850 |
Why?
|
| Metals | 1 | 2025 | 113 | 0.840 |
Why?
|
| Mass Screening | 2 | 2019 | 531 | 0.820 |
Why?
|
| Uterine Rupture | 1 | 2023 | 5 | 0.820 |
Why?
|
| Environmental Exposure | 2 | 2017 | 247 | 0.820 |
Why?
|
| Air Pollutants | 1 | 2025 | 127 | 0.800 |
Why?
|
| HIV Infections | 8 | 2021 | 2535 | 0.760 |
Why?
|
| Cardiovascular Diseases | 3 | 2023 | 728 | 0.750 |
Why?
|
| Premature Birth | 1 | 2023 | 94 | 0.730 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 134 | 0.720 |
Why?
|
| Bayes Theorem | 3 | 2023 | 121 | 0.710 |
Why?
|
| Bronchitis, Chronic | 1 | 2021 | 16 | 0.710 |
Why?
|
| Kidney Failure, Chronic | 2 | 2019 | 239 | 0.640 |
Why?
|
| Viral Load | 3 | 2020 | 344 | 0.630 |
Why?
|
| Pregnancy Trimester, First | 2 | 2017 | 21 | 0.630 |
Why?
|
| Female | 28 | 2025 | 23980 | 0.620 |
Why?
|
| Aluminum | 2 | 2017 | 39 | 0.620 |
Why?
|
| Infant, Newborn | 6 | 2025 | 960 | 0.620 |
Why?
|
| Humans | 40 | 2025 | 42113 | 0.620 |
Why?
|
| Peritoneal Dialysis | 1 | 2019 | 9 | 0.600 |
Why?
|
| Young Adult | 13 | 2025 | 4928 | 0.600 |
Why?
|
| Adult | 19 | 2025 | 13437 | 0.600 |
Why?
|
| Carbon | 2 | 2017 | 127 | 0.570 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 72 | 0.570 |
Why?
|
| Models, Statistical | 2 | 2016 | 190 | 0.560 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 531 | 0.560 |
Why?
|
| Renal Dialysis | 1 | 2019 | 124 | 0.550 |
Why?
|
| Lead | 1 | 2019 | 101 | 0.550 |
Why?
|
| Impulsive Behavior | 1 | 2018 | 54 | 0.540 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 112 | 0.530 |
Why?
|
| Abruptio Placentae | 1 | 2017 | 6 | 0.520 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 164 | 0.510 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2021 | 12 | 0.510 |
Why?
|
| Adolescent | 16 | 2022 | 5949 | 0.470 |
Why?
|
| Infant Mortality | 2 | 2012 | 64 | 0.450 |
Why?
|
| Stroke | 1 | 2019 | 336 | 0.450 |
Why?
|
| Pregnancy Trimesters | 1 | 2014 | 15 | 0.450 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 249 | 0.450 |
Why?
|
| Income | 1 | 2016 | 160 | 0.440 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2016 | 225 | 0.440 |
Why?
|
| Health Behavior | 1 | 2019 | 568 | 0.440 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 297 | 0.430 |
Why?
|
| Feeding Behavior | 1 | 2018 | 461 | 0.420 |
Why?
|
| Social Class | 1 | 2016 | 286 | 0.410 |
Why?
|
| Acute Coronary Syndrome | 2 | 2023 | 42 | 0.390 |
Why?
|
| After-Hours Care | 1 | 2012 | 4 | 0.380 |
Why?
|
| Cross-Sectional Studies | 11 | 2023 | 3073 | 0.380 |
Why?
|
| Exercise | 1 | 2018 | 674 | 0.360 |
Why?
|
| Air Pollution, Indoor | 2 | 2021 | 50 | 0.330 |
Why?
|
| Odds Ratio | 3 | 2017 | 584 | 0.320 |
Why?
|
| Prevalence | 5 | 2022 | 1593 | 0.310 |
Why?
|
| Kuwait | 2 | 2019 | 4 | 0.300 |
Why?
|
| Middle Aged | 9 | 2020 | 11790 | 0.300 |
Why?
|
| Hypertension | 1 | 2016 | 817 | 0.300 |
Why?
|
| Obesity | 2 | 2021 | 1129 | 0.290 |
Why?
|
| Logistic Models | 2 | 2025 | 1001 | 0.280 |
Why?
|
| Retrospective Studies | 7 | 2023 | 2466 | 0.270 |
Why?
|
| Male | 15 | 2020 | 22745 | 0.260 |
Why?
|
| United States | 7 | 2023 | 5068 | 0.250 |
Why?
|
| Anti-HIV Agents | 2 | 2020 | 475 | 0.230 |
Why?
|
| Gestational Age | 2 | 2022 | 195 | 0.220 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 263 | 0.200 |
Why?
|
| Hysterectomy | 1 | 2023 | 39 | 0.200 |
Why?
|
| Incidence | 2 | 2017 | 1052 | 0.190 |
Why?
|
| Educational Status | 2 | 2016 | 335 | 0.190 |
Why?
|
| Cadmium | 1 | 2021 | 54 | 0.180 |
Why?
|
| Aged | 3 | 2019 | 7958 | 0.180 |
Why?
|
| Hypersensitivity | 1 | 2021 | 32 | 0.170 |
Why?
|
| Age Distribution | 2 | 2019 | 249 | 0.170 |
Why?
|
| Gonorrhea | 1 | 2021 | 24 | 0.170 |
Why?
|
| Malnutrition | 1 | 2021 | 44 | 0.170 |
Why?
|
| Chlamydia | 1 | 2021 | 45 | 0.170 |
Why?
|
| Bangladesh | 2 | 2021 | 26 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2021 | 1570 | 0.160 |
Why?
|
| Cannabis | 1 | 2022 | 90 | 0.160 |
Why?
|
| Triage | 1 | 2020 | 34 | 0.160 |
Why?
|
| Cross Infection | 1 | 2020 | 47 | 0.160 |
Why?
|
| Intention | 1 | 2020 | 103 | 0.150 |
Why?
|
| Fetal Blood | 1 | 2019 | 48 | 0.150 |
Why?
|
| Models, Theoretical | 1 | 2020 | 230 | 0.150 |
Why?
|
| Risk-Taking | 2 | 2020 | 456 | 0.150 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 135 | 0.150 |
Why?
|
| Telomere | 1 | 2019 | 59 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 118 | 0.140 |
Why?
|
| Self Efficacy | 1 | 2020 | 211 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2020 | 225 | 0.140 |
Why?
|
| Employment | 1 | 2019 | 83 | 0.140 |
Why?
|
| Vaccination | 1 | 2020 | 332 | 0.140 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 156 | 0.140 |
Why?
|
| Linear Models | 1 | 2019 | 310 | 0.140 |
Why?
|
| Overweight | 2 | 2021 | 248 | 0.140 |
Why?
|
| Child | 4 | 2020 | 3381 | 0.140 |
Why?
|
| Infant | 3 | 2021 | 1142 | 0.130 |
Why?
|
| Sexual Behavior | 2 | 2020 | 634 | 0.130 |
Why?
|
| beta-Lactamases | 3 | 2021 | 34 | 0.130 |
Why?
|
| Drug Resistance, Viral | 1 | 2016 | 67 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 40 | 0.120 |
Why?
|
| Smoking Cessation | 1 | 2023 | 583 | 0.120 |
Why?
|
| Cognition | 1 | 2020 | 458 | 0.120 |
Why?
|
| Papillomavirus Vaccines | 1 | 2018 | 168 | 0.120 |
Why?
|
| Substance-Related Disorders | 2 | 2020 | 825 | 0.110 |
Why?
|
| Cesarean Section | 2 | 2012 | 63 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 959 | 0.110 |
Why?
|
| Parents | 1 | 2018 | 359 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 222 | 0.110 |
Why?
|
| Sodium | 1 | 2014 | 101 | 0.110 |
Why?
|
| Magnesium | 1 | 2014 | 93 | 0.110 |
Why?
|
| Potassium | 1 | 2014 | 109 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 637 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2018 | 350 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 363 | 0.100 |
Why?
|
| Urban Population | 1 | 2016 | 364 | 0.100 |
Why?
|
| Smoking | 3 | 2020 | 1019 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 285 | 0.100 |
Why?
|
| Sex Factors | 2 | 2016 | 1004 | 0.100 |
Why?
|
| Rural Population | 1 | 2016 | 352 | 0.100 |
Why?
|
| Iron | 1 | 2014 | 247 | 0.100 |
Why?
|
| Marital Status | 1 | 2012 | 46 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2790 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 162 | 0.090 |
Why?
|
| Delivery, Obstetric | 1 | 2012 | 47 | 0.090 |
Why?
|
| Asthma | 1 | 2015 | 410 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 512 | 0.080 |
Why?
|
| Time Factors | 2 | 2012 | 1845 | 0.080 |
Why?
|
| Fetal Death | 1 | 2010 | 18 | 0.080 |
Why?
|
| Twins | 1 | 2010 | 18 | 0.080 |
Why?
|
| Fetal Development | 1 | 2010 | 34 | 0.080 |
Why?
|
| India | 2 | 2020 | 105 | 0.080 |
Why?
|
| Age Factors | 1 | 2012 | 1135 | 0.070 |
Why?
|
| Socioeconomic Factors | 3 | 2020 | 1221 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 415 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 580 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2021 | 1515 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2023 | 44 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1679 | 0.050 |
Why?
|
| Fetal Macrosomia | 1 | 2021 | 12 | 0.050 |
Why?
|
| Cats | 1 | 2021 | 80 | 0.040 |
Why?
|
| Birth Weight | 1 | 2021 | 94 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 71 | 0.040 |
Why?
|
| Biomass | 1 | 2021 | 66 | 0.040 |
Why?
|
| Allergens | 1 | 2021 | 64 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 138 | 0.040 |
Why?
|
| Dust | 1 | 2021 | 55 | 0.040 |
Why?
|
| Dogs | 1 | 2021 | 201 | 0.040 |
Why?
|
| Carbapenems | 1 | 2020 | 8 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2020 | 78 | 0.040 |
Why?
|
| Enterobacteriaceae | 1 | 2020 | 29 | 0.040 |
Why?
|
| Health Status | 1 | 2023 | 432 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 115 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 74 | 0.040 |
Why?
|
| Fetus | 1 | 2019 | 101 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 437 | 0.040 |
Why?
|
| Registries | 1 | 2020 | 430 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2021 | 325 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 915 | 0.030 |
Why?
|
| Emotions | 1 | 2020 | 251 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 309 | 0.030 |
Why?
|
| Poverty | 1 | 2020 | 395 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1058 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 288 | 0.030 |
Why?
|
| Absenteeism | 1 | 2015 | 14 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 224 | 0.030 |
Why?
|
| Texas | 1 | 2016 | 428 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 680 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 421 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 178 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 792 | 0.030 |
Why?
|
| SEER Program | 1 | 2014 | 157 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 268 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 727 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 353 | 0.020 |
Why?
|
| Missouri | 1 | 2012 | 7 | 0.020 |
Why?
|
| Live Birth | 1 | 2012 | 9 | 0.020 |
Why?
|
| Maternal Age | 1 | 2012 | 34 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 858 | 0.020 |
Why?
|
| Pregnancy in Adolescence | 1 | 2012 | 34 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 847 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1051 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1728 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 710 | 0.020 |
Why?
|
| Animals | 1 | 2021 | 16694 | 0.010 |
Why?
|